(Q62042588)
Statements
A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of Single Doses of NNC0165-1875 as Monotherapy and in Combination With Semaglutide in Subjects With Overweight or Obesity (English)
0 references
15 October 2018
0 references
11 September 2019
0 references
88
0 references
18 year
0 references
55 year
0 references